BardelliAlberto University of Torino / IFOM ETSItaly

Alberto Bardelli is Professor at the Dept. of Oncology at the University of Torino School of Medicine and Director of the Laboratory of Molecular Oncology at the Candiolo Cancer Institute in Italy. Graduated cum laude at the University of Torino, he holds a Ph.D. in Biochemistry and Molecular biology from the University College London (UCL) followed by a post-doctoral fellowship in the laboratory directed by Bert Vogelstein at the Howard Hughes Medical Institute at the Johns Hopkins University in Baltimore. Prof Bardelli and his laboratory at the Candiolo Cancer Institute have pioneered the combined use of genomics, patients’ avatars and liquid biopsies to accurately predict tumor's response and resistance to targeted agents. Discoveries from his group led to the development of innovative diagnostic tests, and therapeutic regimens currently in clinical use for colorectal cancer patients. Prof Bardelli has been President of the European Association for Cancer Research (EACR) and received several awards, including the ESMO Translational Research Award in 2017 and the Guido Venosta Award, given by AIRC (Italian Association for Cancer Research) and Presidency of Italian Republic, in 2020.